株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ヘパリンの世界市場:収益・市場動向・成長率・市場シェアの分析・予測

Heparin Market - Global Revenue, Trends, Growth, Share, Size and Forecast

発行 Scalar Market Research 商品コード 531374
出版日 ページ情報 英文 105 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.05円で換算しております。
Back to Top
ヘパリンの世界市場:収益・市場動向・成長率・市場シェアの分析・予測 Heparin Market - Global Revenue, Trends, Growth, Share, Size and Forecast
出版日: 2016年10月01日 ページ情報: 英文 105 Pages
概要

当レポートでは、世界のヘパリンの市場を調査し、市場の定義と概要、市場への各種影響因子および市場機会の分析、サプライチェーンの分析、製品区分・投与経路・用途・地域/主要国別の動向と市場規模の推移と予測、競合環境、企業プロファイルなどをまとめています。

第1章 市場概要

第2章 エグゼクティブサマリー

第3章 市場力学

  • 成長推進因子
  • 成長抑制因子
  • 市場機会
  • 市場動向

第4章 産業分析

  • サプライチェーン分析
  • サプライヤー分析
  • 価格分析

第5章 市場分析・予測:製品区分別

  • 市場概要
  • 市場シェア
  • 収益
  • 出荷規模
  • 製品区分
    • 未分画ヘパリン (UFH)
    • 低分子量ヘパリン (LMWH)
    • 超低分子量ヘパリン (ULMWH)

第6章 市場分析・予測:投薬経路別

  • 市場概要
  • 市場シェア
  • 収益
  • 投薬経路
    • 静注
    • 皮下注射

第7章 市場分析・予測:用途別

  • 市場概要
  • 市場シェア
  • 収益
  • 出荷規模
  • 用途
    • 臨床試験
    • 医療機器
    • 静脈血栓塞栓症

第8章 市場分析・予測:地域別

  • 地域概要
  • 市場シェア
  • 収益
  • 出荷規模
  • 北米
    • 国別
      • 米国
      • カナダ
    • 製品区分別
    • 投薬経路別
    • 用途別
  • 欧州
    • 国別
      • ドイツ
      • 英国
      • フランス
      • イタリア
      • その他
    • 製品区分別
    • 投薬経路別
    • 用途別
  • アジア太平洋
    • 国別
      • 中国
      • インド
      • ロシア
      • オーストラリア
      • インドネシア
      • その他
    • 製品区分別
    • 投薬経路別
    • 用途別
  • 中東・アフリカ
    • 国別
      • サウジアラビア
      • イラン
      • エジプト
      • 南アフリカ
      • ナイジェリア
      • ケニア
      • その他
    • 製品区分別
    • 投薬経路別
    • 用途別
  • ラテンアメリカ
    • 国別
      • ブラジル
      • アルゼンチン
      • コロンビア
      • その他
    • 製品区分別
    • 投薬経路別
    • 用途別

第9章 競合環境

  • 市場シェア分析

第10章 主要企業

  • Sanofi S.A.
  • Glaxo SmithKline plc
  • Pfizer Inc.
  • Leo Pharma A/S
  • Aspen Holdings
  • Fresenius Kabi AG
  • Baxter International Inc.

第11章 SCALARの全方位的市場レビュー

第12章 付録

目次
Product Code: HC103

Title:
Heparin Market
by Product (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra Lower Molecular Weight Heparin(ULMWH)), Root of Administration (IV Injection, Subcutaneous Injection), Applications (Clinical Trials, Medical Devices, Venous Thromboembolism) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022.

Global Heparin Market worth USD 758 billion in 2016 and expected to reach USD 1020 billion by 2022, at a CAGR of 5.07% from 2016 to 2022.

Our industry experts anticipate that within the heparin market, the Ultra Low Molecular Weight Heparin (ULMWH) is expected to dominate the product segment, growing at a CAGR ranging from 10% to 1.5% during the forecast period. In addition, venous thrombosis is anticipated to dominate the application segment of the heparin market, growing at a CAGR ranging from 1% to 5% by 2022. The Asia-Pacific region is expected to be the largest geographic segment in the market, growing at a CAGR ranging from 5% to 1.0% during the forecast period.

KEY BENEFITS OF THE REPORT:

  • In-depth analysis of the market segments that will showcase the greatest growth potential
  • Information about the technological advancements influencing the growth of the global market
  • Extensive analysis of the key players dominating the competitive landscape of this market

KEY PREMIUM INDUSTRY INSIGHTS:

  • Growing population of the people suffering from Venous Thromboembolism (VTE) and obesity is one of the major driving factors for the heparin market.
  • The declining imports from China and the growing adoption of the new oral anticoagulants are also some of the major drivers for the market for heparin.
  • The possibility of the regulatory approval of synthetic heparin and the comeback of bovine heparin in the United States will create new opportunities for the heparin manufacturers and the crude heparin suppliers to make strides in this market.
  • On the other hand, the risks and harmful side effects from porcine heparin and the stringent regulatory scenario in some geographical areas are some of the challenges faced by the global heparin market.

MARKET SEGMENTATION:

This report the heparin market by the following segments:

Heparin Market, by Product Segments

  • Unfractionated Heparin(UFH)
  • Low Molecular Weight Heparin(LMWH)
  • Ultra Low Molecular Weight Heparin(ULMWH)

Heparin Market, by Route of Administration

  • Intravenous Injection
  • Subcutaneous Injection

Heparin Market, by Applications

  • Clinical Trials
  • Medical Devices
  • Venous Thromboembolism

KEY MARKET PLAYERS:

Key players in the heparin market include:

  • Sanofi
  • Leo Pharma
  • Pfizer
  • GlaxosmitheKline
  • Baxter Healthcare
  • Fresnius Kabi AG
  • Aspen Holdings

Table of Contents

1 MARKET OVERVIEW

  • 1.1 Definitions
  • 1.2 Research Methodology
    • 1.2.1 Primary Data
    • 1.2.2 Secondary Data
    • 1.2.3 Machine Learning
    • 1.2.4 Research Scope
    • 1.2.5 Assumptions
    • 1.2.6 Years Considered
    • 1.2.7 Currency & Pricing
  • 1.3 Market Segmentation
  • 1.4 Key Objectives & Benefits of the Report
    • 1.4.1 Objectives of the Report
    • 1.4.2 Key Benefits of the Report

2 EXECUTIVE SUMMARY

3 MARKET DYNAMICS

  • 3.1 Market Drivers
    • 3.1.1 Increase in ageing population and life expectancy
    • 3.1.2 Rise in Hospital-Acquired Infection patients (HAI) across the globe especially in African countries
    • 3.1.3 Increase in diabetic patients and obesity related disorders-
    • 3.1.4 Rising affluence in emerging markets, especially in countries such as India, China, and South Africa
  • 3.2 Market Restraints
    • 3.2.1 Declining imports and rising contamination of crude heparin from China, creating difficulties for other heparin manufacturers-
    • 3.2.2 Growing adoption of new oral anticoagulants such as warfarin-
  • 3.3 Opportunities
    • 3.3.1 Regulatory approval of synthetic heparin will create new opportunities for manufacturers-
    • 3.3.2 Rising opportunities for clinical trials and medical devices applications in Asia-Pacific for heparin-
  • 3.4 Trends
    • 3.4.1 Formation of new generic formulations for blood coagulation and other new therapeutics-
    • 3.4.2 Increased spending on hip, knee and shoulder replacement surgeries-

4 INDUSTRY ANALYSIS

  • 4.1 Supply Chain Analysis
  • 4.2 Suppliers Analysis
  • 4.3 Pricing Analysis

5 GLOBAL HEPARIN MARKET, BY PRODUCT SEGMENTS

  • 5.1 Market Overview
  • 5.2 Market Share Segmentation
  • 5.3 Revenue Segmentation
  • 5.4 Volume Segmentation
  • 5.5 Products
    • 5.5.1 Unfractionated Heparin (UFH)
    • 5.5.2 Low Molecular Weight Heparin (LMWH)
    • 5.5.3 Ultra Low Molecular Weight Heparin (ULMWH)

6 HEPARIN MARKET, BY ROUTE OF ADMINISTRATION (ROA)

  • 6.1 Market Overview
  • 6.2 Market Share Segmentation
  • 6.3 Revenue Segmentation
  • 6.4 Route of Administration
    • 6.4.1 Intravenous Injection
    • 6.4.2 Subcutaneous Injection

7 HEPARIN MARKET, BY APPLICATIONS

  • 7.1 Market Overview
  • 7.2 Market Share Segmentation
  • 7.3 Revenue Segmentation
  • 7.4 Volume Segmentation
  • 7.5 Applications
    • 7.5.1 Clinical Trials
    • 7.5.2 Medical Devices
    • 7.5.3 Venous Thromboembolism

8 HEPARIN MARKET, BY REGIONS

  • 8.1 Geographic Overview
  • 8.2 Market Share Segmentation
  • 8.3 Revenue Segmentation
  • 8.4 Volume Segmentation
  • 8.5 North America
    • 8.5.1 By Regions
      • 8.5.1.1 U.S.
      • 8.5.1.2 Canada
    • 8.5.2 By Product Segments
    • 8.5.3 By Route of Administration
    • 8.5.4 By Applications
  • 8.6 Europe
    • 8.6.1 By Regions
      • 8.6.1.1 Germany
      • 8.6.1.2 U.K
      • 8.6.1.3 France
      • 8.6.1.4 Italy
      • 8.6.1.5 Rest of Europe
    • 8.6.2 By Product Segments
    • 8.6.3 By Route of Administration
    • 8.6.4 By Applications
  • 8.7 Asia-Pacific
    • 8.7.1 By Regions
      • 8.7.1.1 China
      • 8.7.1.2 India
      • 8.7.1.3 Russia
      • 8.7.1.4 Australia
      • 8.7.1.5 Indonesia
      • 8.7.1.6 Rest of Asia-Pacific
    • 8.7.2 By Product Segments
    • 8.7.3 By Route of Administration
    • 8.7.4 By Applications
  • 8.8 Middle East& Africa
    • 8.8.1 By Regions
      • 8.8.1.1 Saudi Arabia
      • 8.8.1.2 Iran
      • 8.8.1.3 Egypt
      • 8.8.1.4 South Africa
      • 8.8.1.5 Nigeria
      • 8.8.1.6 Kenya
      • 8.8.1.7 Rest of Middle East& Africa
    • 8.8.2 By Product Segments
    • 8.8.3 By Route of Administration
    • 8.8.4 By Applications
  • 8.9 Latin America
    • 8.9.1 By Regions
      • 8.9.1.1 Brazil
      • 8.9.1.2 Argentina
      • 8.9.1.3 Columbia
      • 8.9.1.4 Rest of Latin America
    • 8.9.2 By Product Segments
    • 8.9.3 By Route of Administration
    • 8.9.4 By Applications

9 COMPETITIVE LANDSCAPE

  • 9.1 Market Share Analysis

10 KEY MARKET PLAYERS

  • 10.1 Sanofi S.A.
    • 10.1.1 Overview
    • 10.1.2 Key Strategies
    • 10.1.3 Recent Developments
  • 10.2 Glaxo SmithKline plc
    • 10.2.1 Overview
    • 10.2.2 Key Strategies
    • 10.2.3 Recent Developments
  • 10.3 Pfizer Inc.
    • 10.3.1 Overview
    • 10.3.2 Key Strategies
    • 10.3.3 Recent Developments
  • 10.4 Leo Pharma A/S
    • 10.4.1 Overview
    • 10.4.2 Key Strategies
    • 10.4.3 Recent Developments
  • 10.5 Aspen Holdings
    • 10.5.1 Overview
    • 10.5.2 Key Strategies
    • 10.5.3 Recent Developments
  • 10.6 Fresenius Kabi AG
    • 10.6.1 Overview
    • 10.6.2 Key Strategies
    • 10.6.3 Recent Developments
  • 10.7 Baxter International Inc.
    • 10.7.1 Overview
    • 10.7.2 Key Strategies
    • 10.7.3 Recent Developments

11 SCALAR 360 DEGREE MARKET PERSPECTIVE

12 APPENDIX

  • 12.1 Related Reports

List of Tables

  • Table 1. Primary Data
  • Table 2. Primary Sources
  • Table 3. Secondary Data
  • Table 4. Advantages of Machine Learning-based Forecasts
  • Table 5. Assumptions
  • Table 6. Years Considered
  • Table 7. Global Heparin Market Size (US$ million), (2016-2022)
  • Table 8. Impact Analysis: Global Heparin Market Drivers
  • Table 9. Impact Analysis: Global Heparin Market Restraints
  • Table 10. Global Heparin API Production Capacity (trillion units), (2014-2022)
  • Table 11. Global Heparin API Production Capacity (trillion units), By Geography (2014-2022)
  • Table 12. Pricing of Top Heparin Products with Average Market Price(2015)
  • Table 13. Heparin Pricing Analysis, By Product Segments
  • Table 14. Market Attractiveness for different Heparin Product Segments
  • Table 15. Global Heparin Market Size (US$ million), By Product Segments (2014-2022)
  • Table 16. Global Heparin Volume (million units), By Product Segments (2014-2022)
  • Table 17. Global Unfractionated Heparin Market Size (US$ million), By Regions (2014-2022)
  • Table 18. Global Low Molecular Weight Heparin Market Size (US$ million),By Regions (2014-2022)
  • Table 19. Global Ultra Low Molecular Weight Market Size (US$ million), By Regions (2014-2022)
  • Table 20. Global Heparin Market Size (US$ million), By Route of Administration (2014-2022)
  • Table 21. Global Heparin Market for Intravenous Injection; Market Size (US$ million) (2014-2022)
  • Table 22. Global Heparin Market for Subcutaneous Injection; Market Size (US$ million) (2014-2022)
  • Table 23. Global Heparin Market Size (US$ million), By Applications (2014-2022)
  • Table 24. Global Heparin Volume (million units), By Applications (2014-2022)
  • Table 25. Global Heparin Market for Clinical Trials; Market Size (US$ million) (2014-2022)
  • Table 26. Global Heparin Market for Medical Devices; Market Size (US$ million) (2014-2022)
  • Table 27. Global Heparin Market for Venous Thromboembolism; Market Size (US$ million) (2014-2022)
  • Table 28. Heparin Market Prospects, by Geography (2016-2022)
  • Table 29. Global Heparin Market Size (US$ million), By Regions (2014-2022)
  • Table 30. Global Heparin Market; Market Size (US$ million), By Major Countries (2014-2022)
  • Table 31. Global Heparin Volume (million units), By Regions (2014-2022)
  • Table 32. Heparin Market in North America; Market Size (US$ million) and Annual Growth Rate (2014-2022)
  • Table 33. Heparin Market in U.S.; Market Size (US$ million), (2014-2022)
  • Table 34. Heparin Market in Canada; Market Size (US$ million), (2014-2022)
  • Table 35. Heparin Market in North America; Market Size (US$ million), By Product Segments (2014-2022)
  • Table 36. Heparin Market in North America; Market Size (US$ Million), By Route of Administration (ROA) (2014-2022)
  • Table 37. Heparin Market in North America; Market Size (US$ million), By Applications (2014-2022)
  • Table 38. Heparin Market in Europe; Market Size (US$ million) and Annual Growth Rate (2014-2022)
  • Table 39. Heparin Market in Germany; Market Size (US$ million), (2014-2022)
  • Table 40. Heparin Market in U.K; Market Size (US$ million), (2014-2022)
  • Table 41. Heparin Market in France; Market Size (US$ million), (2014-2022)
  • Table 42. Heparin Market in Italy; Market Size (US$ million), (2014-2022)
  • Table 43. Heparin Market in Rest of Europe; Market Size (US$ million), (2014-2022)
  • Table 44. Heparin Market in Europe; Market Size (US$ million), By Product Segments (2014-2022)
  • Table 45. Heparin Market in Europe; Market Size (US$ million), By Route of Administration (ROA) (2014-2022)
  • Table 46. Heparin Market in Europe; Market Size (US$ million), By Applications (2014-2022)
  • Table 47. Heparin Market in Asia-Pacific; Market Size (US$ million) and Annual Growth Rate (2014-2022)
  • Table 48. Heparin Market in China; Market Size (US$ million), (2014-2022)
  • Table 49. Heparin Market in India; Market Size (US$ million), (2014-2022)
  • Table 50. Heparin Market in Russia; Market Size (US$ million), (2014-2022)
  • Table 51. Heparin Market in Australia; Market Size (US$ million), (2014-2022)
  • Table 52. Heparin Market in Indonesia; Market Size (US$ million), (2014-2022)
  • Table 53. Heparin Market in Rest of Asia-Pacific; Market Size (US$ million), (2014-2022)
  • Table 54. Heparin Market in Asia-Pacific; Market Size (US$ million), By Product Segments (2014-2022)
  • Table 55. Heparin Market in Asia-Pacific; Market Size (US$ million), By Route of Administration (ROA) (2014-2022)
  • Table 56. Heparin Market in Asia-Pacific; Market Size (US$ million), By Applications (2014-2022)
  • Table 57. Heparin Market in Middle East& Africa; Market Size (US$ million) and Annual Growth Rate (2014-2022)
  • Table 58. Heparin Market in Saudi Arabia; Market Size (US$ million), (2014-2022)
  • Table 59. Heparin Market in Iran; Market Size (US$ million), (2014-2022)
  • Table 60. Heparin Market in Egypt; Market Size (US$ million), (2014-2022)
  • Table 61. Heparin Market in South Africa; Market Size (US$ million), (2014-2022)
  • Table 62. Heparin Market in Nigeria; Market Size (US$ million), (2014-2022)
  • Table 63. Heparin Market in Kenya; Market Size (US$ million), (2014-2022)
  • Table 64. Heparin Market in Rest of Middle East& Africa; Market Size (US$ million), (2014-2022)
  • Table 65. Heparin Market in Middle East & Africa; Market Size (US$ million), By Product Segments (2014-2022)
  • Table 66. Heparin Market in Middle East & Africa; Market Size (US$ million), By Route of Administration (ROA) (2014-2022)
  • Table 67. Heparin Market in Middle East & Africa; Market Size (US$ million), By Applications (2014-2022)
  • Table 68. Heparin Market in Latin America; Market Size (US$ million) and Annual Growth Rate (2014-2022)
  • Table 69. Heparin Market in Brazil; Market Size (US$ million), (2014-2022)
  • Table 70. Heparin Market in Argentina; Market Size (US$ million), (2014-2022)
  • Table 71. Heparin Market in Columbia; Market Size (US$ million), (2014-2022)
  • Table 72. Heparin Market in Rest of Latin America; Market Size (US$ million), (2014-2022)
  • Table 73. Heparin Market in Latin America; Market Size (US$ million), By Product Segments (2014-2022)
  • Table 74. Heparin Market in North America; Market Size (US$ million), By Route of Administration (ROA) (2014-2022)
  • Table 75. Heparin Market in Latin America; Market Size (US$ million), By Applications (2014-2022)
  • Table 76. Revenue from Heparin (US$ million), By Major Players (2014 & 2015)
  • Table 77. Acronyms

List of Figures

  • Figure 1. Research Methodology
  • Figure 2. Global Heparin Market
  • Figure 3. Global Heparin Market Share (%), By Regions (2015)
  • Figure 4. Global Heparin Market Share (%), By Product Segments (2015)
  • Figure 5. Global Heparin Market Share (%), By Route of Administration (2015)
  • Figure 6. Global Heparin Market Share (%), By Applications (2015)
  • Figure 7. Global Heparin Market Dynamics
  • Figure 8. Supply Chain Analysis: Global Heparin Market
  • Figure 9. Global Heparin API Production Market Share (%), By Major Suppliers(2015)
  • Figure 10. Heparin API Production Capacity (trillion units), By Major Suppliers (2015)
  • Figure 11. Global Heparin Market by Product Segments: Market Size & Market Penetration(2015)
  • Figure 12. Global Heparin Market Share(%), By Product Segments (2015 & 2022)
  • Figure 13. Global Heparin Market Size (US$ million), By Product Segments (2014-2022)
  • Figure 14. Global Heparin Market By Volume (million units), By Product Segments (2015)
  • Figure 15. Global Heparin Volume (Million Units), By Product Segments(2015 & 2022)
  • Figure 16. Global Unfractionated Heparin Market Size (US$ million), By Regions (2015 & 2022)
  • Figure 17. Global Low Molecular Weight Heparin Market Size (US$ million), By Regions (2015 & 2022)
  • Figure 18. Global Ultra Low Molecular Heparin Market Size (US$ million), By Regions (2015 & 2022)
  • Figure 19. Global Heparin Market Size (US$ million), By Route of Administration (2015)
  • Figure 20. Global Heparin Market Share (%), By Route of Administration (2015 & 2022)
  • Figure 21. Global Heparin Market Size (US$ million), By Route of Administration (2014-2022)
  • Figure 22. Global Heparin Market for Intravenous Injection; Market Size (US$ million) (2015 & 2022)
  • Figure 23. Global Heparin Market for Subcutaneous Injection; Market Size (US$ million) (2015 & 2022)
  • Figure 24. Global Heparin Market Size (US$ million), By Applications (2015)
  • Figure 25. Global Heparin Market Share (%), By Applications (2015 & 2022)
  • Figure 26. Global Heparin Market Size (US$ million), By Applications (2014-2022)
  • Figure 27. Global Heparin Market By Volume (million units) (2015)
  • Figure 28. Global Heparin Volume (million units), By Applications (2015 & 2022)
  • Figure 29. Global Heparin Market for Clinical Trials; Market Size (US$ million) (2015 & 2022)
  • Figure 30. Global Heparin Market for Medical Devices; Market Size (US$ million) (2015 & 2022)
  • Figure 31. Global Heparin Market for Venous Thromboembolism; Market Size (US$ million) (2015 & 2022)
  • Figure 32. Global Heparin Market Share (%), By Major Regions(2015 & 2022)
  • Figure 33. Top 5 Countries, By Market Share (%) (2015)
  • Figure 34. Top 5 Countries with Highest CAGR% (2016-2022)
  • Figure 35. Global Heparin Volume (million units), By Regions (2015)
  • Figure 36. Heparin Market in North America; Snapshot (2015)
  • Figure 37. Heparin Market in North America; Market Size (US$ million)(2014-2022)
  • Figure 38. Heparin Market in North America; Market Size (US$ million),By Product Segments (2014-2022)
  • Figure 39. Heparin Market in North America; Market Size (US$ million),By Route of Administration (2014-2022)
  • Figure 40. Heparin Market in North America; Market Size (US$ million),By Applications (2014-2022)
  • Figure 41. Heparin Market in Europe; Snapshot (2015)
  • Figure 42. Heparin Market in Europe; Market Size (US$ million)(2014-2022)
  • Figure 43. Heparin Market in Europe; Market Size (US$ million),By Product Segments (2014-2022)
  • Figure 44. Heparin Market in Europe; Market Size (US$ million),By Route of Administration (2014-2022)
  • Figure 45. Heparin Market in Europe; Market Size (US$ million),By Applications (2014-2022)
  • Figure 46. Heparin Market in Asia-Pacific; Snapshot (2015)
  • Figure 47. Heparin Market in Asia-Pacific; Market Size (US$ million)(2014-2022)
  • Figure 48. Heparin Market in Asia-Pacific; Market Size (US$ million),By Product Segments (2014-2022)
  • Figure 49. Heparin Market in Asia-Pacific; Market Size (US$ million),By Route of Administration (2014-2022)
  • Figure 50. Heparin Market in Asia-Pacific; Market Size (US$ million),By Applications (2014-2022)
  • Figure 51. Heparin Market in Middle East& Africa; Snapshot (2015)
  • Figure 52. Heparin Market in Middle East& Africa; Market Size (US$ million) (2014-2022)
  • Figure 53. Heparin Market in Middle East& Africa; Market Size (US$ million),By Product Segments(2014-2022)
  • Figure 54. Heparin Market in Middle East& Africa; Market Size (US$ million),By Route of Administration (2014-2022)
  • Figure 55. Heparin Market in Middle East& Africa; Market Size (US$ million),By Applications (2014-2022)
  • Figure 56. Heparin Market in Middle Latin America; Snapshot (2015)
  • Figure 57. Heparin Market in Latin America; Market Size (US$ million) (2014-2022)
  • Figure 58. Heparin Market in Latin America; Market Size (US$ million),By Product Segments(2014-2022)
  • Figure 59. Heparin Market in Latin America; Market Size (US$ million),By Route of Administration (2014-2022)
  • Figure 60. Heparin Market in Latin America; Market Size (US$ million),By Applications (2014-2022)
  • Figure 61. Market Share (%) of Major Players (2015)
  • Figure 62. Dominant Players
Back to Top